|
Back to Home » January 2021 News » Hansa Biopharma provides business update incl. certain key financials ahead of the JP Morgan Global Healthcare Conference |
Hansa Biopharma provides business update incl. certain key financials ahead of the JP Morgan Global Healthcare Conference |
January 11, 2021
Commercial launch activities for Idefirix® progressing as planned Patient recruitment in the two phase 2 studies in AMR and GBS was reinitiated in December 2020 Year-end cash position of SEK 1.4 billion LUND, Sweden, Jan. 11, 2021 /PRNewswire/ -- Hansa Biopharma, the leader in...
Source URL: https://www.prnewswire.com:443/news-releases/hansa-biopharma-provides-business-update-incl-certain-key-financials-ahead-of-the-jp-morgan-global-healthcare-conference-301204955.html
|
|
|
|
